DNLI NASDAQ · Healthcare · FY 2025-12-31

Denali Therapeutics Inc.

0.06.212.418.624.9ABVfair 6.49buy ≤ 1.62EPVnot valid for this companyEBVnot valid for this companyDBVnot valid for this companyprice 23.02 USD
ABV EPV EBV DBV fair value / share buy at or below (margin of safety applied) margin-of-safety band current price values in USD
Verdict
Avoid
Buy zone
Overvalued
Archetype
Distressed/Deficit
Confidence
●○○ Low · 1/4

Price
23.020 USD
Market cap
3.60B USD
P / B
3.55
P / E
EPS
-2.970
DPS / yield
(0.0%)
NAV / share
6.491
Graham number
Z'' score
3.62
Piotroski F
2 / 9
Beneish M
ROIC vs WACC
-59.8% vs 10.7%

See the full orchestrator pipeline — solvency gate, lens cascade, reconciliation, archetype, decision, and confidence.

Subscribe to unlock this and every other tab for every company.

See the full ABV lens breakdown — gates, steps, and verdict.

Subscribe to unlock this and every other tab for every company.

See the full EPV lens breakdown — gates, steps, and verdict.

Subscribe to unlock this and every other tab for every company.

See the full EBV lens breakdown — gates, steps, and verdict.

Subscribe to unlock this and every other tab for every company.

See the full DBV lens breakdown — gates, steps, and verdict.

Subscribe to unlock this and every other tab for every company.